Discussion
Immunosuppressive treatments can reduce the risk of disease relapses in people with neuromyelitis optica spectrum disorder (NMOSD) who test negative for known disease-driving antibodies, a review study showed. Because relapses in these patients often lead to permanent disability, the findings suggest that immunosuppressive treatment should be given early to…